Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
bioSyntagma
company
About
A precision medicine company with novel technology enabling advanced diagnostics and biomarker discovery
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $196K
- Industries
- Biotechnology,Life Science
- Founded date
- Apr 2, 2015
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$1.30M
bioSyntagma has raised a total of
$1.30M
in funding over 2 rounds. Their latest funding was raised on
Mar 19, 2018 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 19, 2018 | Grant | $196K | 1 | — | — | Detail |
| Feb 6, 2018 | Grant | $892.08K | 1 |
National Science Foundation
|
— | Detail |
| Jan 1, 2017 | Grant | $214K | 1 |
National Science Foundation
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
2
bioSyntagma is funded by 2 investors.
National Science Foundation
and National Institutes of Health
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
National Institutes of Health
|
— | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
